Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Activated microglia enhance neurogenesis via trypsinogen secretion.
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Movement disorders in multiple sclerosis.
Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System.
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.
Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Regulation of claudins in blood-tissue barriers under physiological and pathological states.
Uveitis as a prognostic factor in multiple sclerosis.
A case of multiple sclerosis with pure, massive superficial demyelination.
Functional plasticity in MS: Friend or foe?
Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.
Daclizumab for relapsing remitting multiple sclerosis.

Pages